Form 8-K - Current report:
SEC Accession No. 0001140361-21-015739
Filing Date
2021-05-04
Accepted
2021-05-04 16:39:20
Documents
2
Period of Report
2021-04-30
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K brhc10024036_8k.htm 8-K 20052
2 EXHIBIT 10.1 brhc10024036_ex10-1.htm EX-10.1 24412
  Complete submission text file 0001140361-21-015739.txt   45556
Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 617-621-7722
Cyclerion Therapeutics, Inc. (Filer) CIK: 0001755237 (see all company filings)

EIN.: 831895370 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38787 | Film No.: 21889196
SIC: 2834 Pharmaceutical Preparations